Why is CytoSorbents Corp. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -6.21% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -21.28
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -40.00%, its profits have risen by 44.2%
3
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 14.90% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -40.00% returns
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is CytoSorbents Corp. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
CytoSorbents Corp.
-40.0%
-0.34
76.85%
S&P 500
14.9%
0.77
19.29%
Quality key factors
Factor
Value
Sales Growth (5y)
-1.20%
EBIT Growth (5y)
-6.21%
EBIT to Interest (avg)
-21.28
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.23
Sales to Capital Employed (avg)
1.34
Tax Ratio
9.65%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
27.67%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.53
EV to EBIT
-2.90
EV to EBITDA
-3.22
EV to Capital Employed
2.89
EV to Sales
1.42
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-99.60%
ROE (Latest)
-114.91%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
13What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -9.89 MM
NET PROFIT(HY)
Higher at USD -1.02 MM
RAW MATERIAL COST(Y)
Fallen by -15.43% (YoY
OPERATING PROFIT(Q)
Highest at USD -2.26 MM
OPERATING PROFIT MARGIN(Q)
Highest at -23.84 %
-8What is not working for the Company
INTEREST(HY)
At USD 1.26 MM has Grown at 64.17%
DEBT-EQUITY RATIO
(HY)
Highest at 220.42 %
Here's what is working for CytoSorbents Corp.
Operating Cash Flow
Highest at USD -9.89 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Higher at USD -1.02 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Profit
At USD -1.02 MM has Grown at 84.56%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Operating Profit
Highest at USD -2.26 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at -23.84 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Raw Material Cost
Fallen by -15.43% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for CytoSorbents Corp.
Interest
At USD 1.26 MM has Grown at 64.17%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Debt-Equity Ratio
Highest at 220.42 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






